1. Home
  2. NUWE vs LEO Comparison

NUWE vs LEO Comparison

Compare NUWE & LEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nuwellis Inc.

NUWE

Nuwellis Inc.

N/A

Current Price

$2.30

Market Cap

2.9M

Sector

Health Care

ML Signal

N/A

Logo BNY Mellon Strategic Municipals Inc.

LEO

BNY Mellon Strategic Municipals Inc.

N/A

Current Price

$6.27

Market Cap

402.8M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
NUWE
LEO
Founded
1999
1987
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Trusts Except Educational Religious and Charitable
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
2.9M
402.8M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
NUWE
LEO
Price
$2.30
$6.27
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
50.8K
200.2K
Earning Date
11-12-2025
01-01-0001
Dividend Yield
N/A
4.01%
EPS Growth
N/A
N/A
EPS
N/A
0.04
Revenue
$8,167,999.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$10.48
N/A
P/E Ratio
N/A
$152.00
Revenue Growth
N/A
N/A
52 Week Low
$2.02
$4.98
52 Week High
$70.14
$6.50

Technical Indicators

Market Signals
Indicator
NUWE
LEO
Relative Strength Index (RSI) 44.40 50.38
Support Level $2.10 $6.25
Resistance Level $2.86 $6.32
Average True Range (ATR) 0.19 0.05
MACD 0.01 0.00
Stochastic Oscillator 26.21 61.11

Price Performance

Historical Comparison
NUWE
LEO

About NUWE Nuwellis Inc.

Nuwellis Inc is a medical technology company focused on developing, manufacturing, and commercializing a medical device used in ultrafiltration therapy, including the Aquadex FlexFlow and the Aquadex SmartFlow systems. The Aquadex Smartflow System removes excess fluid from patients suffering from fluid overload who have not responded to medical management, including diuretics. Nuwellis has one reportable segment: fluid overload.

About LEO BNY Mellon Strategic Municipals Inc.

BNY Mellon Strategic Municipals, Inc. is a diversified closed-end management investment company. The fund's investment objective is to maximize current income exempt from federal income tax to the extent consistent with the preservation of capital. Its products are Equity and Fixed Income Mutual Funds, Retail Money Market Funds, Government/Treasury Money Market Funds, Institutional Money Market Funds, and others. BNY Mellon and its affiliates, including BNYM Investment Adviser, INA and others involved in the management, sales, investment activities, business operations or distribution of the Fund, are engaged in businesses and have interests other than that of managing the Fund.

Share on Social Networks: